Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 1
1995 1
1996 3
1997 4
1998 4
1999 4
2000 1
2001 1
2002 1
2003 1
2004 1
2005 2
2006 1
2007 1
2010 1
2014 1
2016 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Increased insulin like growth factor binding protein acid labile subunit concentration"
Page 1
Splanchnic exchange of insulin-like growth factor binding protein-1 (IGFBP-1), IGF-I and acid-labile subunit (ALS) during normo- and hyper-insulinaemia in healthy subjects.
Fernqvist-Forbes E, Ekberg K, Lindgren BF, Brismar K. Fernqvist-Forbes E, et al. Clin Endocrinol (Oxf). 1999 Sep;51(3):327-32. doi: 10.1046/j.1365-2265.1999.00775.x. Clin Endocrinol (Oxf). 1999. PMID: 10469012 Clinical Trial.
OBJECTIVE: The main source of circulating IGF-I, insulin like growth factor binding protein-1 (IGFBP-1) and acid-labile subunit (ALS) is considered to be the liver, but their production rates have not been determined …
OBJECTIVE: The main source of circulating IGF-I, insulin like growth factor binding protein-1 (IGF …
High protein diets do not attenuate decrements in testosterone and IGF-I during energy deficit.
Henning PC, Margolis LM, McClung JP, Young AJ, Pasiakos SM. Henning PC, et al. Metabolism. 2014 May;63(5):628-32. doi: 10.1016/j.metabol.2014.02.007. Epub 2014 Feb 17. Metabolism. 2014. PMID: 24641883 Clinical Trial.
OBJECTIVE: Energy deficit (ED) diminishes fat-free mass (FFM) with concomitant reductions in anabolic hormone secretion. A modest increase in protein to recommended dietary allowance (RDA) levels during ED minimally attenuates decrements in insulin-like gr …
OBJECTIVE: Energy deficit (ED) diminishes fat-free mass (FFM) with concomitant reductions in anabolic hormone secretion. A modest increase i …
Complex formation by human insulin-like growth factor-binding protein-3 and human acid-labile subunit in growth hormone-deficient rats.
Lewitt MS, Saunders H, Phuyal JL, Baxter RC. Lewitt MS, et al. Endocrinology. 1994 Jun;134(6):2404-9. doi: 10.1210/endo.134.6.7514998. Endocrinology. 1994. PMID: 7514998
Insulin-like growth factor-binding protein-3 (IGFBP-3), after first associating with IGF-I or IGF-II, is able to associate with the acid-labile subunit (ALS) and form a 140-kDa complex. ...We conclude that ALS circula …
Insulin-like growth factor-binding protein-3 (IGFBP-3), after first associating with IGF-I or IGF- …
The acid-labile subunit of human ternary insulin-like growth factor-binding protein complex in girls with central precocious puberty before and during gonadotropin-releasing hormone analog therapy.
Cisternino M, Draghi M, Lauriola S, Scarcella D, Bernasconi S, Cavallo L, De Luca F, Lomeo A, Tatò L. Cisternino M, et al. J Clin Endocrinol Metab. 2002 Oct;87(10):4629-33. doi: 10.1210/jc.2002-020308. J Clin Endocrinol Metab. 2002. PMID: 12364447 Clinical Trial.
The aim of the study was to evaluate serum acid-labile subunit (ALS) concentrations and their relationship with other parameters of the human ternary IGF-I-binding protein (IGFBP) complex in girls with central precocious puberty (CPP) bef …
The aim of the study was to evaluate serum acid-labile subunit (ALS) concentrations and their relationship with …
Growth hormone stimulates transcription of the gene encoding the acid-labile subunit (ALS) of the circulating insulin-like growth factor-binding protein complex and ALS promoter activity in rat liver.
Ooi GT, Cohen FJ, Tseng LY, Rechler MM, Boisclair YR. Ooi GT, et al. Mol Endocrinol. 1997 Jun;11(7):997-1007. doi: 10.1210/mend.11.7.9942. Mol Endocrinol. 1997. PMID: 9178759
The growth-promoting activity of GH, the principal hormonal determinant of body size, is mediated by insulin-like growth factor I (IGF-I). Most of the IGF-I in plasma circulates in a 150-kDa complex that contains IGF-binding protein …
The growth-promoting activity of GH, the principal hormonal determinant of body size, is mediated by insulin-like gr …
Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein.
Kanety H, Silbergeld A, Klinger B, Karasik A, Baxter RC, Laron Z. Kanety H, et al. Eur J Endocrinol. 1997 Dec;137(6):626-30. doi: 10.1530/eje.0.1370626. Eur J Endocrinol. 1997. PMID: 9437227
A minority of patients with Laron syndrome have normal serum GH binding protein (GHBP), indicating that the defect is elsewhere than in the extracellular domain of the GH receptor. We have evaluated the effect of long-term IGF-I treatment on serum IGF-binding …
A minority of patients with Laron syndrome have normal serum GH binding protein (GHBP), indicating that the defect is elsewher …
Regulation of the insulin-like growth factor system by insulin in burn patients.
Lang CH, Fan J, Frost RA, Gelato MC, Sakurai Y, Herndon DN, Wolfe RR. Lang CH, et al. J Clin Endocrinol Metab. 1996 Jul;81(7):2474-80. doi: 10.1210/jcem.81.7.8675563. J Clin Endocrinol Metab. 1996. PMID: 8675563
The aim of the present investigation was to determine whether there is a net uptake of insulin-like growth factor I (IGF-I) or IGF-binding proteins (IGFBPs) by the leg after burn injury and to elucidate the regulatory role of insulin …
The aim of the present investigation was to determine whether there is a net uptake of insulin-like growth factor …
Effects of growth hormone on insulin-like growth factors and binding proteins before and after renal transplantation.
van Renen MJ, Harrer S, Jureidini KF, Martin AA. van Renen MJ, et al. Pediatr Nephrol. 1996 Aug;10(4):483-7. doi: 10.1007/s004670050144. Pediatr Nephrol. 1996. PMID: 8865248 Clinical Trial.
Three short children with severe chronic renal failure were treated with recombinant human growth hormone (rhGH) for 2 years. Each received a transplant in the 2nd year. Serum collected before and during rhGH therapy was analysed retrospectively by Western ligand blot and …
Three short children with severe chronic renal failure were treated with recombinant human growth hormone (rhGH) for 2 years. Each re …
Regulation of the acid-labile subunit of the insulin-like growth factor ternary complex in patients with insulin-dependent diabetes mellitus and severe burns.
Bereket A, Wilson TA, Blethen SL, Sakurai Y, Herndon DN, Wolfe RR, Lang CH. Bereket A, et al. Clin Endocrinol (Oxf). 1996 May;44(5):525-32. doi: 10.1046/j.1365-2265.1996.726547.x. Clin Endocrinol (Oxf). 1996. PMID: 8762728
OBJECTIVE: Little information is available regarding the regulation of serum acid-labile subunit (ALS) in human disease. We have studied alterations in serum ALS of the insulin-like growth factor (IGF) ternary complex in children w …
OBJECTIVE: Little information is available regarding the regulation of serum acid-labile subunit (ALS) in human disease …
The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitus.
Cheetham TD, Holly JM, Baxter RC, Meadows K, Jones J, Taylor AM, Dunger DB. Cheetham TD, et al. J Endocrinol. 1998 Apr;157(1):81-7. doi: 10.1677/joe.0.1570081. J Endocrinol. 1998. PMID: 9614361 Clinical Trial.
The long term therapeutic potential of recombinant human (rh) IGF-I administration in insulin-dependent diabetes mellitus (IDDM) may be determined by changes in the IGF binding proteins (IGFBPs) and thus the bioavailability of IGF-I. We have therefore studied …
The long term therapeutic potential of recombinant human (rh) IGF-I administration in insulin-dependent diabetes mellitus (IDDM) may …
31 results